Buckley Wealth Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,000
Closed -$206K 130
2022
Q2
$206K Hold
4,000
0.07% 137
2022
Q1
$295K Hold
4,000
0.08% 122
2021
Q4
$572K Buy
4,000
+2,000
+100% +$344K 0.17% 93
2021
Q3
$415K Buy
+2,000
New +$441K 0.13% 101

Other funds holding NVAX

Buckley Wealth Management's NVAX Position: Q3 2022 in Review

Buckley Wealth Management sold out of Novavax (NVAX) in Q3 2022, closing a stake of 4,000 shares — an estimated $206K sold.

Buckley Wealth Management first reported a position in NVAX in Q3 2021 and held it in 4 quarters. The position peaked at $572K in Q4 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Buckley Wealth Management reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Buckley Wealth Management sold 4,000 Novavax shares in Q3 2022, an estimated $206K.
  • Buckley Wealth Management first reported a position in Novavax in Q3 2021 and held it in 4 quarters.
  • Buckley Wealth Management's Novavax position peaked at $572K in Q4 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Buckley Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.